Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue diseasejeanfrancoismaisonJun 31 min readRated NaN out of 5 stars.https://pubmed.ncbi.nlm.nih.gov/40333188/
ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosishttps://pubmed.ncbi.nlm.nih.gov/40467521/
Targeting CD117 on hematopoietic stem and progenitor cells impairs CAR T cell activityhttps://pubmed.ncbi.nlm.nih.gov/40450523/
Comments